NEW ORLEANS — January 31, 2026 — Breakthrough research presented at the 2026 Society of Thoracic Surgeons Annual Meeting shows that additional lymph node evaluation is needed during surgery for ...

SAN ANTONIO -- Thoracic surgeons were fired up about minimum expectations for surgical lymph node assessment in conjunction with lung cancer resection during a debate at the Society of Thoracic ...

Incidence of non-metastatic extrathoracic lesions detected by whole-body FDG PET-CT imaging in patients with non-small-cell lung cancer Background: The aim of this study was to investigate the pattern ...

Nonurothelial recurrence of UTUC to the lungs or lymph nodes only portends better survival compared with multisite metastases. Nearly 1 in 5 patients who undergo radical nephroureterectomy (RNU) for ...

Evaluation of the hilar and mediastinal lymph nodes is part of the surgical treatment of non-small cell lung cancer (NSCLC). It is also vital to the staging of lung cancer, which determines the need ...

The Journal of Clinical Oncology podcast, hosted by Dr. Davide Soldato, presents analyses and discussions centered on the latest findings published in ASCO’s esteemed Journal of Clinical Oncology.

The process of staging lung cancer accurately plays a major role in establishing treatment options and predicting survival. Proper lung cancer staging demands a thorough understanding of TNM-8, which ...

Lung cancer is cancer that starts in your lungs. It is the leading cause of cancer death among men and women. Finding lung cancer early before it spreads improves your chances of beating the disease.

Medically reviewed by Doru Paul, MD Key Takeaways Survival rates for stage 3 lung cancer can vary between 13% to 36% depending on the subtype.Stage 3a lung cancer is often treated with surgery and ...